BDBM335738 1-(4-{4-[(1H-Pyrrolo[2,3-b]pyridin-5-ylmethyl)-amino]-pyrrolo[3,2-c]pyridin-1-ylmethyl}-benzyl)-1H-pyridin-2-one::US9738641, 3
SMILES: O=c1ccccn1Cc1ccc(Cn2ccc3c(NCc4cnc5[nH]ccc5c4)nccc23)cc1
InChI Key: InChIKey=KOTMMIHTHZXOHT-UHFFFAOYSA-N
Data: 2 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kallikrein 1 (Homo sapiens (Human)) | BDBM335738 (1-(4-{4-[(1H-Pyrrolo[2,3-b]pyridin-5-ylmethyl)-ami...) | PDB UniProtKB/SwissProt UniProtKB/TrEMBL antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.69E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Kalvista Pharmaceuticals Limited US Patent | Assay Description KLK1 inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8, 185; Shori ... | US Patent US9738641 (2017) BindingDB Entry DOI: 10.7270/Q2M047K7 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Plasma kallikrein (Homo sapiens (Human)) | BDBM335738 (1-(4-{4-[(1H-Pyrrolo[2,3-b]pyridin-5-ylmethyl)-ami...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.46E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Kalvista Pharmaceuticals Limited US Patent | Assay Description Plasma kallikrein inhibitory activity in vitro was determined using standard published methods (see e.g. Johansen et al., Int. J. Tiss. Reac. 1986, 8... | US Patent US9738641 (2017) BindingDB Entry DOI: 10.7270/Q2M047K7 | |||||||||||
More data for this Ligand-Target Pair |